CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib

Triparna Sen(The University of Texas MD Anderson Cancer Center), Pan Tong(The University of Texas MD Anderson Cancer Center), C. Allison Stewart(The University of Texas MD Anderson Cancer Center), Sandra Cristea(Stanford University), Aly Valliani(The University of Texas MD Anderson Cancer Center), David S. Shames, Abena B. Redwood(The University of Texas MD Anderson Cancer Center), You Hong Fan(The University of Texas MD Anderson Cancer Center), Lerong Li(The University of Texas MD Anderson Cancer Center), Bonnie S. Glisson(The University of Texas MD Anderson Cancer Center), John D. Minna(The University of Texas Southwestern Medical Center), Julien Sage(Stanford University), Don L. Gibbons(The University of Texas MD Anderson Cancer Center), Helen Piwnica‐Worms(The University of Texas MD Anderson Cancer Center), John V. Heymach(The University of Texas MD Anderson Cancer Center), Jing Wang(The University of Texas MD Anderson Cancer Center), Lauren A. Byers
Cancer Research
May 10, 2017
Cited by 195

Abstract

.


Related Papers

No related papers found

Powered by citation graph analysis